Clinical Trials Insight: 700034427

Trial Profile

Clinical Trials Insight: 700034427

Phase of Trial: Phase I

Latest Information Update: 11 Jun 2008

At a glance

  • Drugs SL 017 (Primary)
  • Indications Actinic keratosis; Skin cancer
  • Focus Adverse reactions
  • Sponsors Quest PharmaTech
  • Most Recent Events

    • 11 Jun 2008 New trial record.
    • 02 Jun 2008 Results data have been reported in a Quest PharmaTech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top